Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
J. B. Elder. (1986) Recent Experimental and Clinical Studies on the Pharmacology of Colloidal Bismuth Subcitrate. Scandinavian Journal of Gastroenterology 21:sup122, pages 14-16.
Read now
Read now
Articles from other publishers (20)
C Ivanov, O Petkov, P Petrov, M Taskov, R Athanassova, E Tsvetkova, V Kotsev, G Lyutakov, G Nikolov & E Savov. (1996)
Synthesis, Gastroprotective, Antisecretory and Anti-helicobacter Effect of
N
-[3-(3-(1-Piperidinylmethyl) phenoxy)propyl]-hydroxyacetamide 2-Hydroxypropane-1,2,3-tricarboxylate Bismuth (3+) Complex (MX1)-MX1
. Journal of Pharmacy and Pharmacology 48:3, pages 297-301.
Crossref
Crossref
Paola Dotto, Marina Ferrana, Nadia Dal Bó, Simonetta Salandin, Stefano Kusstatscher, Mauro Cassaro, Mario Plebani, Giuseppe Battaglia, Fabio Vianello, Massimo Rugge & Francesco Di Mario. (1995) Cytoprotective effects of colloidal bismuth subcitrate in patients with ulcer disease. Current Therapeutic Research 56:7, pages 684-689.
Crossref
Crossref
Eiji Asato, Cor M. Hol, Frans B. Hulsbergen, Nico T.M. Klooster & Jan Reedijk. (1993) Synthesis, structure and spectroscopic properties of bismuth citrate compounds part II. Comparison between crystal structures of solid bismuth citrates and commercial CBS, using thermal and spectroscopic methods. Inorganica Chimica Acta 214:1-2, pages 159-167.
Crossref
Crossref
R. STABLES, C. J. CAMPBELL, N. M. CLAYTON, J. W. CLITHEROW, C. J. GRINHAM, A. A. McCOLM, A. McLAREN & M. A. TREVETHICK. (2007) Gastric anti‐secretory, mucosal protective, anti‐pepsin and anti‐Helicobacter properties of ranitidine bismuth citrate. Alimentary Pharmacology & Therapeutics 7:3, pages 237-246.
Crossref
Crossref
D J Munoz, C Tasman-Jones & J Pybus. (1992) Effect of Helicobacter pylori infection on colloidal bismuth subcitrate concentration in gastric mucus.. Gut 33:5, pages 592-596.
Crossref
Crossref
A Ahmed, P R Salmon, C R Cairns, M Hobsley & J R Hoult. (1992) Eicosanoid synthesis in duodenal ulcer disease: decrease in leukotriene C4 by colloidal bismuth subcitrate.. Gut 33:2, pages 159-163.
Crossref
Crossref
Shiann Pan, Chen-Hsuing Liao, Gi-Shih Lien & Sheng-Hsuan Chen. (1991) Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine. Gastroenterology 101:5, pages 1187-1191.
Crossref
Crossref
Efthimios Eleftheriadis, Katerina Kotzampassi, Emmanouel Tzartinoglou, Aziz Salem & Homeros Aletras. (1991) Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: Gastric mucosal blood flow after CBS treatment. Gastroenterologia Japonica 26:3, pages 283-286.
Crossref
Crossref
E. Eleftheriadis, K. Kotzampassi, V. Tzioufa, M. Karamouzis & H. Aletras. (1990) Effects of famotidine on gastric mucus of the rat. Research in Experimental Medicine 190:1, pages 219-222.
Crossref
Crossref
Paul E. O'Brien, Gary Frydman, Robert Holmes, Cathy Malcontenti & David Phelan. (1990) Evaluation of putative cytoprotective properties of antiulcer drugs using quantitative histological techniques. Digestive Diseases and Sciences 35:9, pages 1130-1139.
Crossref
Crossref
Bronislaw L. Slomiany, Xiaoying Wang, Danuta Palecz, Kazuichi Okazaki & Amalia Slomiany. (1990) Participation of Phosphoinositides in Gastric Mucosal Protection by Colloidal Bismuth Subcitrate against Ethanol-Induced Injury. Alcoholism: Clinical and Experimental Research 14:4, pages 580-583.
Crossref
Crossref
Jerzy Piotrowski, Jan Bilski, Hidefumi Nishikawa, Amalia Slomiany & Bronislaw L. Slomiany. (1990) Enhancement in gastric mucus gel qualities with colloidal bismuth subcitrate administration. European Journal of Pharmacology 184:1, pages 55-63.
Crossref
Crossref
S M Hinsull & D Bellamy. (1990) Effect of repeated colloidal bismuth subcitrate treatment on the response of the rat gastric mucosa to the presence of luminal ethanol.. Gut 31:4, pages 389-396.
Crossref
Crossref
James W. Freston. (1990) Overview of Medical Therapy of Peptic Ulcer Disease. Gastroenterology Clinics of North America 19:1, pages 121-140.
Crossref
Crossref
Konstanze Vogt, Mechthild Warrelmann & Helmut Hahn. (1989) The Minimum Inhibitory Concentrations of Various Bismuth Salts against Campylobacter pylori. Zentralblatt f?r Bakteriologie 271:3, pages 304-310.
Crossref
Crossref
Janneke De Wal. (1988) Mechanism of action of nonantisecretory agents. Digestive Diseases and Sciences 33:10, pages 1342-1342.
Crossref
Crossref
Stephen G. Chiverton & Richard H. Hunt. (1988) Medical regimens in short- and long-term ulcer management. Baillière's Clinical Gastroenterology 2:3, pages 655-676.
Crossref
Crossref
G. N. J. Tytgat, C. Y. Nio & B. T. J. van den Berg. 1988. Campylobacter pylori. Campylobacter pylori
195
203
.
F Cipollini & F Altilia. (1987) Comparison of tri‐potassium di‐citrato bismuthate (TDB) with ranitidine in healing and relapse of gastric ulcer. International Journal of Clinical Practice 41:4, pages 707-709.
Crossref
Crossref
Stuart Patton. (1974) Malonaldehyde, lipid oxidation, and the thiobarbituric acid test. Journal of the American Oil Chemists Society 51:3, pages 114-114.
Crossref
Crossref